GL1X · GenesisL1 explorer

Research workbench

Human MALT1(329-729) in complex with a chromane urea containing inhibitor

Analyse Human MALT1(329-729) in complex with a chromane urea containing inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7AK1
Type
protein
Length
351 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Mucosa-associated lymphoid tissue lymphoma translocation protein 1
EC
3.4.22.-
UniProt
Q9UDY8
Ligands
RJH, MG
Pockets
3 · best druggability 0.71

Structure

x-ray diffraction · 1 distinct chain · 26% helix, 32% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMucosa-associated lymphoid tissue lymphoma translocation protein 1 (EC 3.4.22.-)protein35126% helix, 32% strandQ9UDY8

Ligands and binding sites

  • RJH · 1-(3-chloranyl-4-methoxy-phenyl)-3-[7-[(3~{S})-3-(methoxymethyl)morpholin-4-yl]-2-methyl-pyrazolo[1,5-a]pyrimidin-6-yl]urea · ligand · chains A
  • MG · Magnesium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12550.710.8529RJH
21770.480.7628empty
31020.370.7515empty

Compared structures

  • 7AK1 · Human MALT1(329-729) in complex with a chromane urea containing inhibitor · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9UDY8 · AlphaFold monomer V2.0 prediction for mucosa-associated lymphoid tissue lymphoma… · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.